SCHEMBL15326412

SCHEMBL15326412

CCCNC(=O)C1OC(C)(C)OC1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA4 P43681 1/20 0.36
BCHE P06276 1/20 0.35
POLB P06746 2/20 0.34
PGD P52209 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
EPHX1 P07099 2/20 0.32
HPGD P15428 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16639433 0.87 MAPK1 (0.40) MAPK1NPSR1PGDCA2
SCHEMBL15325113 0.87 MAPK1 (0.40) MAPK1NPSR1PGDCA2
SCHEMBL12631722 0.79 EPHX1 (0.42) MAPK1NPSR1BCHEPOLBMMP2
SCHEMBL16488181 0.77 CHRNB2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL20091180 0.77 CA2 (0.41) MAPK1NPSR1PGDALDH1A1KMT2A
SCHEMBL15326452 0.76 MAPK1 (0.42) MAPK1NPSR1PGDCA2
SCHEMBL4396176 0.72 TSHR (0.50) POLBALDH1A1KMT2AMEN1EPHX1
SCHEMBL16640743 0.72 MAPK1 (0.34) MAPK1NPSR1PGD
SCHEMBL18658568 0.72 MAPK1 (0.34) MAPK1NPSR1PGD
SCHEMBL23616275 0.71 CA2 (0.40) MAPK1NPSR1POLBPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2837629-B1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE ASYMCHEM LABORATORIES (TIANJIN) CO LTD (CN) 2017-03-22 EP disclosed
US-9371326-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-21 US disclosed
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-30 US disclosed
EP-2837629-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE Asymchem Laboratories (Tianjin) Co., Ltd (CN) 2015-02-18 EP disclosed
WO-2013152608-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE 凯莱英医药集团(天津)股份有限公司 (CN) 2013-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE DHCR7, CYP51A1, HMGCR MAPK1 2845/4885NPSR1 328/4885CHRNB2 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.